Athens Medical C.S.A. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	275.75	269.85	258.36	233.42	226
Revenue Growth (YoY)	2.19%	4.44%	10.69%	3.28%	20.53%
Cost of Revenue	219.61	209.08	191.81	176.61	168.21
Gross Profit	56.14	60.76	66.56	56.81	57.79
Selling, General & Admin	52.85	48.73	45.5	40.63	37.26
Other Operating Expenses	-4.78	-3.12	-2	-2.39	-2.91
Operating Expenses	48.07	45.81	43.68	38.54	35.05
Operating Income	8.07	14.96	22.87	18.28	22.73
Interest Expense	-11.72	-10.7	-9.33	-7.64	-6.55
Interest & Investment Income	-	0.32	0.33	0.12	0.2
Other Non Operating Income (Expenses)	0.65	-0.13	-0.13	-0.13	-0.13
EBT Excluding Unusual Items	-3.01	4.45	13.75	10.64	16.26
Gain (Loss) on Sale of Assets	-	0.05	-0.05	0.08	-1.37
Other Unusual Items	-	-	-	-	0.45
Pretax Income	-3.01	4.5	13.7	10.71	15.34
Income Tax Expense	1.61	2.61	5.54	3.8	3.3
Earnings From Continuing Operations	-4.62	1.89	8.16	6.92	12.04
Earnings From Discontinued Operations	-	-	-	-	3.1
Net Income to Company	-4.62	1.89	8.16	6.92	15.14
Minority Interest in Earnings	-0.05	-0.11	-0.08	-0.07	-0.09
Net Income	-4.67	1.78	8.08	6.85	15.05
Net Income to Common	-4.67	1.78	8.08	6.85	15.05
Net Income Growth	-	-77.99%	18.05%	-54.51%	283.54%
Shares Outstanding (Basic)	87	87	87	87	87
Shares Outstanding (Diluted)	87	87	87	87	87
Shares Change (YoY)	0.08%	-	-	-	-
EPS (Basic)	-0.05	0.02	0.09	0.08	0.17
EPS (Diluted)	-0.05	0.02	0.09	0.08	0.17
EPS Growth	-	-77.99%	18.05%	-54.51%	283.54%
Free Cash Flow	-11.83	19.82	3.78	-15.75	4.47
Free Cash Flow Per Share	-0.14	0.23	0.04	-0.18	0.05
Dividend Per Share	-	-	0.020	-	0.070
Gross Margin	20.36%	22.52%	25.76%	24.34%	25.57%
Operating Margin	2.93%	5.54%	8.85%	7.83%	10.06%
Profit Margin	-1.69%	0.66%	3.13%	2.93%	6.66%
Free Cash Flow Margin	-4.29%	7.34%	1.46%	-6.75%	1.98%
EBITDA	27.52	25.78	32.85	27.64	31.48
EBITDA Margin	9.98%	9.55%	12.71%	11.84%	13.93%
D&A For EBITDA	19.46	10.83	9.98	9.36	8.75
EBIT	8.07	14.96	22.87	18.28	22.73
EBIT Margin	2.93%	5.54%	8.85%	7.83%	10.06%
Effective Tax Rate	-	58.06%	40.44%	35.44%	21.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.